// App-Quantinova.ai

2693 : Relapse in BCP-ALL predicted by activated signaling in pro-B cell subsets

Researchers

Presenter

  • Zinaida Good

Principal Investigators

  • Jolanda Sarno

  • Astraea Jager

  • Nikolay Samusik

  • Wendy Fantl

  • Nima Aghaeepour

  • Robert Tibshirani

  • Sean C. Bendall

  • Giuseppe Gaipa

  • Andrea Biondi

  • Garry P. Nolan

  • Kara L. Davis

Medical Centers

  • Pediatric Clinic University of Milano Bicocca, Monza, Italy.

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Mismatch repair deficiency

  • Solid malignancies

Biomarkers

  • Phosphorylated signal transducer and activator of transcription 5

  • Phosphorylated-AKT

  • Interleukin-7

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved